We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

38 hedge funds and large institutions have $708K invested in Gyre Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 26 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

12% more funds holding

Funds holding: 34 → 38 (+4)

1.4% less ownership

Funds ownership: 2.11% → 0.71% (-1.4%)

73% less capital invested

Capital invested by funds: $2.63M → $708K (-$1.92M)

92% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 26

Holders
38
Holders Change
+4
Holders Change %
+11.76%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
26
Closed
4
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
-$155K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$65.7K
2
HF
HRT Financial
New York
+$20.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$14.8K
4
E
Ergoteles
New York
+$12.7K
5
Simplex Trading
Simplex Trading
Illinois
+$11.3K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$705K
2
Renaissance Technologies
Renaissance Technologies
New York
-$380K
3
NCM
Nantahala Capital Management
Connecticut
-$181K
4
Citadel Advisors
Citadel Advisors
Florida
-$154K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$70.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$6.65K -$3.29K -866 -29%
Goldman Sachs
27
Goldman Sachs
New York
$4.43K +$5.43K +1,428 New
KWM
28
Keebeck Wealth Management
Illinois
$4.14K -$5.07K -1,334 -50%
Citadel Advisors
29
Citadel Advisors
Florida
$3.28K -$154K -40,505 -97%
AWA
30
Arete Wealth Advisors
Illinois
$2K +$2.62K +690 New
CG
31
Cutler Group
California
$1K -$1.39K -366 -50%
ASN
32
Advisory Services Network
Georgia
$207 -$251 -66 -50%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$57 -$72 -19 -51%
Osaic Holdings
34
Osaic Holdings
Arizona
$45 -$57 -15 -52%
Wells Fargo
35
Wells Fargo
California
$38 -$46 -12 -50%
Vanguard Group
36
Vanguard Group
Pennsylvania
– -$705K -178,099 Closed
VF
37
Virtu Financial
New York
– -$69K -17,496 Closed
Lazard Asset Management
38
Lazard Asset Management
New York
– -$28K -7,096 Closed
Jane Street
39
Jane Street
New York
– -$16.5K -4,174 Closed
TRCT
40
Tower Research Capital (TRC)
New York
– -$357 -94 -51%
JP Morgan Chase
41
JP Morgan Chase
New York
– -$15 -4 -57%
1
2

GYRE Hedge Fund Activity: Q1 2023 in Review

38 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q1 2023, worth a combined $708K — down 73% from $2.63M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new GYRE positions and 4 closed out — a net gain of 4 holders — while 2 added to existing stakes and 26 trimmed.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $65.7K. The largest seller was Vanguard Group, exiting entirely with an estimated $705K sold.

  • 38 institutional investors held Gyre Therapeutics (GYRE) as of Q1 2023, up from 34 in Q4 2022.
  • Funds reported $708K of Gyre Therapeutics stock for Q1 2023, down 73% quarter-over-quarter.
  • 8 funds opened new Gyre Therapeutics positions in Q1 2023 and 4 closed out, a net change of +4 holders.
  • The largest Gyre Therapeutics buyer in Q1 2023 was Acadian Asset Management, an estimated $65.7K added.
  • The largest Gyre Therapeutics seller in Q1 2023 was Vanguard Group, an estimated $705K sold.

Based on aggregated 13F filings for Q1 2023.